Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Novartis AG (NVS)

-NYSE
102.46 Down 0.85(0.82%) Apr 17, 4:02PM EDT
Add to Portfolio
Prev Close:103.31
Open:102.61
Bid:102.46 x 1800
Ask:102.48 x 1500
1y Target Est:104.77
Beta:0.7
Next Earnings Date:N/A
Day's Range:101.87 - 102.81
52wk Range:83.71 - 103.80
Volume:1,244,351
Avg Vol (3m):1,757,690
Market Cap:245.76B
P/E (ttm):24.81
EPS (ttm):4.13
Div & Yield:2.82 (2.80%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVSDown 0.82%245.76B
MRKDown 1.66%161.44B
PFEDown 0.43%214.76B
SNYDown 0.88%135.14B

Key Statistics

Forward P/E (1 yr):18.49
P/S (ttm):4.62
Ex-Dividend Date:02-Mar-15

Analysts

Annual EPS Est (Dec-15) :5.18
Quarterly EPS Est (Mar-15) :1.07
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):2.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. Its Pharmaceuticals division offers patented prescription medicines in various therapeutic areas, such as oncology, cardio-metabolic, immunology ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback